BlackRock Investment Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 139 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2016$2,164,000
-5.8%
77,162
-0.3%
0.00%0.0%
Q3 2016$2,298,000
+47.3%
77,368
+0.4%
0.00%
+50.0%
Q2 2016$1,560,000
+160.4%
77,036
+132.0%
0.00%
+100.0%
Q1 2016$599,000
-30.5%
33,202
+1.5%
0.00%0.0%
Q4 2015$862,000
+24.2%
32,708
+0.6%
0.00%0.0%
Q3 2015$694,000
-21.2%
32,525
-2.2%
0.00%0.0%
Q2 2015$881,00033,2480.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2017
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders